Citation Impact
Citing Papers
Zoledronic Acid Has Differential Antitumor Activity in the Pre- and Postmenopausal Bone Microenvironment In Vivo
2014
Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer
2004
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
2019
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
2012
Cancer statistics, 2020
2020 Standout
Breast cancer
2016 Standout
Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007
2008
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
2012
Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells
2017
Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow
2013
Thymoquinone: Potential cure for inflammatory disorders and cancer
2011 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer
2004
Second international consensus guidelines for breast cancer in young women (BCY2)
2016
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Medications in Patients Treated With Therapeutic Plasma Exchange: Prescription Dosage, Timing, and Drug Overdose
2012
A novel rodent papillomavirus isolated from anogenital lesions in its natural host
2008
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Therapeutic Plasma Exchange for Refractory Hemolysis After Brown Recluse Spider (Loxosceles reclusa) Envenomation
2015
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
2014
Structure and function of claudins
2007
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens
2014
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
2015
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Bone health in cancer patients: ESMO Clinical Practice Guidelines
2014
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
2012
Role of bisphosphonates in postmenopausal women with breast cancer
2013
Emerging Biological Principles of Metastasis
2017 Standout
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
2010 StandoutNobel
Cisplatin Overdose
2009
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Coming of age: ten years of next-generation sequencing technologies
2016 Standout
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
2010 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer
2008
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
2011
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
2012
First international consensus guidelines for breast cancer in young women (BCY1)
2014
The Role of Therapeutic Plasma Exchange in Poisonings and Intoxications
2012
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Zeyheria montana Mart. (Bignoniaceae) as source of antioxidant and immunomodulatory compounds with beneficial effects on intestinal inflammation
2014
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
2016 StandoutNobel
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline
2017
Breast Cancer Treatment
2019 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast Cancer
2020
Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer
2015
Disseminated intravascular coagulation. Findings in 346 patients.
1980 Standout
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
2011
Works of Herbert Stoeger being referenced
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
2019
Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation
2006
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype
2015
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
2011
Is first-line single-agent mitoxantrone in the treatment ofhigh-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial
2002
S1-2: Long-Term Follow-Up in ABCSG-12: Significantly Improved Overall Survival with Adjuvant Zoledronic Acid in Premenopausal Patients with Endocrine-Receptor–Positive Early Breast Cancer.
2011
Pathologic complete response (pCR) in patient subgroups: An analysis of ABCSG-24, a phase III, randomized study of anthracycline- and taxane-based neoadjuvant therapy with or without capecitabine in early breast cancer (EBC).
2010
Overall survival with adjuvant zoledronic acid in patients with premenopausal breast cancer with complete endocrine blockade: Long-term results from ABCSG-12.
2011